Mi Deng
机构：Peking University, Peking University Cancer Hospital
发表论文 3 篇 · 总被引 63 次 · h-index 3
代表论文
- Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in vivo CAR-T therapy for inflamm-aging (2025 · Cell Reports Medicine · 被引 38)
- LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway (2024 · Journal of Experimental & Clinical Cancer Research · 被引 19)
- Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in-vivo CAR-T therapy for inflamm-aging (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 6)